Italy: Formulation patents may prevent reimbursement of generics… but, are you innovative enough?

Published date31 January 2018
Law FirmHogan Lovells
AuthorRiccardo Fruscalzo
Subject MatterPatents,Prescription Drugs,Generic Drugs,Reimbursements,Patent Litigation,Patent Infringement,Italy,Intellectual Property Protection,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT